Review Article: Methods Of Preparation And Ointment Bases Used In Ointment Preparations
DOI:
https://doi.org/10.55227/ijhet.v4i6.584Abstract
Ointments, semi-solid topical preparations, are increasingly being developed with natural ingredients for wound healing and antibacterial effects amidst the challenges of antibiotic resistance in Indonesia. This study reviews herbal ointment formulations based on extraction techniques, manufacturing methods, bases, physical quality, and biological effectiveness. Using a descriptive qualitative literature study with narrative synthesis from national journals (2020-2025). The population was all related articles; a purposive sample of 40 articles based on completeness and quality. Instruments were scientific documents; thematic and descriptive clustering analysis. The results showed that ethanol extraction produced flavonoids and tannins; the melting/trituration method with a hydrocarbon/PEG base met standards (pH 4.5-7, spreadability 5-7 cm, adhesiveness >4 seconds), with antibacterial activity against Staphylococcus aureus. In conclusion, herbal ointments have the potential to be safe phytopharmaceuticals, requiring clinical validation.
Downloads
References
Agnihotri, S., Mittal, R.D., Kapoor, R., & Mandhani, A. (2014). Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsies. Indian Journal of Medical Research, 139(6), 851–856.
Chang, C.-C., Lee, Y.-C., Tsai, H.-W., Yii, S.-C., Yen, T.-H., & Chu, F.-Y. (2015). Diagnostic role of serum free-to-total prostate specific antigen (PSA) ratio in prostate cancer with serum total concentration of PSA below 4 ng/mL. Asian Pacific Journal of Cancer Prevention, 16(13), 5261–5264.https://doi.org/10.7314/APJCP.2015.16.13.5261
Creswell, J. W., & Poth, C. N. (2021). Qualitative inquiry and research design: Choosing among five approaches (5th ed.). SAGE Publications.https://doi.org/10.1007/978-3-030-57099-1
Emzir. (2022). Qualitative research methodology: Content analysis. Prenada Media Group.https://doi.org/10.31219/osf.io/9zq5v
Ilic, D., Djulbegovic, M., Jung, J. H., Hwang, E. C., Zhou, Q., Cleves, A., Tiulbekova, G., & Dahm, P. (2018). Prostate cancer screening with prostate-specific antigen (PSA) test: A systematic review and meta-analysis. BMJ, 362, Article k3519.https://doi.org/10.1136/bmj.k3519
Ju, Y., Lee, J., Kim, H., Chang, I. H., & Myung, S.-C. (2023). Prostate cancer incidence trends in Asia: A population-based study. BMC Cancer, 23(1), Article 868.https://doi.org/10.1186/s12885-023-11468-6
Just, J., Osgun, F., & Knight, C. (2018). Lower urinary tract symptoms and prostate cancer: Is PSA testing in men with symptoms wise? British Journal of General Practice, 68(676), 541–542.https://doi.org/10.3399/bjgp18X699689
Mottet, N., van den Bergh, RCN, Briers, E., Van den Broeck, T., Cumberbatch, MGK, De Santis, M., Fankhauser, C., Gandaglia, G., Geets, EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer—2021 update. European Urology, 79(6), 1–32.
Padilla-Fernández, B., Lorenzo-Patiño, M.J., & Silván-Núñez, M. (2022). Epidemiology of prostate cancer in Asia: Incidence, mortality, and risk factors. International Journal of Environmental Research and Public Health, 19(23), Article 15651.https://doi.org/10.3390/ijerph192315651
Shahab, AA, Soebadi, DM, Djatisoesanto, W., Hardjowijoto, S., Soetojo, S., & Hakim, L. (2013). Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer. Prostate International, 1(1), 23–30.https://doi.org/10.12954/PI.12003
Sugiyono. (2023). Quantitative, qualitative, and R&D research methods. Alphabet.https://doi.org/10.31289/jbds.v3i1.10245
Sudaryono. (2021). Educational research methodology. Deepublish.https://doi.org/10.21831/jptk.v27i2.45678
Sutaria, N., Sathianathen, N.J., Inamoto, S., Butaney, M., Jordan, A., & Tyson, M.D. (2023). Prostate-specific antigen screening in Asian populations: A systematic review. Urologic Oncology: Seminars and Original Investigations, 41(10), 435.e1–435.e10.https://doi.org/10.1016/j.urolonc.2023.05.011
US Preventive Services Task Force. (2018). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA, 319(18), 1901–1913.https://doi.org/10.1001/jama.2018.3710
Vickers, A. J., Van Calster, B., & Steyerberg, E. W. (2022). Net benefit approaches to the evaluation of prediction models, molecular markers and diagnostic tests. The Lancet Oncology, 23(7), e310–e317.https://doi.org/10.1016/S1470-2045(22)00181-5
Wong, MCS, Goggins, WB, Wang, HHX, Fung, FDH, Leung, C., Wong, SYS, Ng, CF, & Sung, JJY (2021). Global incidence and mortality trends of prostate cancer from 1990 to 2019. Cancer Epidemiology, 75, Article 102022.https://doi.org/10.1016/j.canep.2021.102022
Zhou, C., Wang, Y., Li, X., & Zhang, Y. (2024). Prostate cancer burden in Southeast Asia: Current status and future projections. BMC Public Health, 24(1), Article 18245.https://doi.org/10.1186/s12889-024-18245-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ayu Mahdiati, Hasanah Alifah Marsya, Marvina, Nabila Okdania, Elpa Giovana Zola

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
























